Attach great importance to postoperative use of bisphosphonate following osteoporotic fracture
10.3760/cma.j.issn.1001-8050.2020.01.005
- VernacularTitle: 重视双膦酸盐在骨质疏松性骨折术后的应用
- Author:
Xin ZHI
1
;
Xiao CHEN
1
;
Jiacan SU
1
Author Information
1. Department of Traumatic Orthopedics, Changhai Hospital, Naval Medical University, Shanghai 200433, China
- Publication Type:Journal Article
- Keywords:
Osteoporosis;
Osteoporotic fractures;
Disphosphonates
- From:
Chinese Journal of Trauma
2020;36(1):14-17
- CountryChina
- Language:Chinese
-
Abstract:
Osteoporotic fracture is a clinical problem resulting in significant morbidity and mortality. The main treatment for osteoporosis is bisphosphonate therapy. Bisphosphonates can inhibit the bone resorption by osteoclasts, inhibit bone alteration, and maintain bone mass. In recent years, basic and clinical studies have not found evidence that the use of bisphosphonates for the inhibition of fracture healing. Therefore, for the patients with confirmed osteoporotic fracture, bisphosphonate should be used to reduce the risk of re-fracture. The authors summarize the related studies in the bisphosphonate intervention for osteoporotic fracture and recommend postoperative use of bisphosphonate for osteoporotic fracture.
